Drug on market to be re-evaluated every 5 years

Published: 2010-09-07 06:58:00

Updated: 2010-09-07 06:58:00

The Korea Food and Drug Administration announced on September 3 that medicines belonging to five therapeutic categories, which was/will be approved within 2013, will be re-evaluated once per year in keeping abreast of the rapid scientific progress.

As for the medicines to be approved after 201...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK